Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
Add more filters










Publication year range
1.
Arch Biochem Biophys ; 758: 110065, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38906311

ABSTRACT

One of important characteristics of Alzheimer's disease is a persistent oxidative/nitrosative stress caused by pro-oxidant properties of amyloid-beta peptide (Aß) and chronic inflammation in the brain. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is easily oxidized under oxidative stress. Numerous data indicate that oxidative modifications of GAPDH in vitro and in cell cultures stimulate GAPDH denaturation and aggregation, and the catalytic cysteine residue Cys152 is important for these processes. Both intracellular and extracellular GAPDH aggregates are toxic for the cells. Interaction of denatured GAPDH with soluble Aß results in mixed insoluble aggregates with increased toxicity. The above-described properties of GAPDH (sensitivity to oxidation and propensity to form aggregates, including mixed aggregates with Aß) determine its role in the pathogenesis of Alzheimer's disease.


Subject(s)
Alzheimer Disease , Amyloid beta-Peptides , Glyceraldehyde-3-Phosphate Dehydrogenases , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Humans , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry , Amyloid beta-Peptides/metabolism , Oxidative Stress , Animals , Oxidation-Reduction
2.
Biochim Biophys Acta Gen Subj ; 1867(9): 130418, 2023 09.
Article in English | MEDLINE | ID: mdl-37355052

ABSTRACT

The aim of this work was to compare the effect of reversible post-translational modifications, S-nitrosylation and S-glutathionylation, on the properties of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and to reveal the mechanism of the relationship between these modifications. Comparison of S-nitrosylated and S-glutathionylated GAPDH showed that both modifications inactivate the enzyme and change its spatial structure, decreasing the thermal stability of the protein and increasing its sensitivity to trypsin cleavage. Both modifications are reversible in the presence of dithiothreitol, however, in the presence of reduced glutathione and glutaredoxin 1, the reactivation of S-glutathionylated GAPDH is much slower (10% in 2 h) compared to S-nitrosylated GAPDH (60% in 10 min). This suggests that S-glutathionylation is a much less reversible modification compared to S-nitrosylation. Incubation of HEK 293 T cells in the presence of H2O2 or with the NO donor diethylamine NONOate results in accumulation of sulfenated GAPDH (by data of Western blotting) and S-glutathionylated GAPDH (by data of immunoprecipitation with anti-GSH antibodies). Besides GAPDH, a protein of 45 kDa was found to be sulfenated and S-glutathionylated in the cells treated with H2O2 or NO. This protein was identified as beta-actin. The results of this study confirm the previously proposed hypothesis based on in vitro investigations, according to which S-nitrosylation of the catalytic cysteine residue (Cys152) of GAPDH with subsequent formation of cysteine sulfenic acid at Cys152 may promote its S-glutathionylation in the presence of cellular GSH. Presumably, the mechanism may be valid in the case of beta-actin.


Subject(s)
Cysteine , Hydrogen Peroxide , Humans , Cysteine/metabolism , Actins/metabolism , HEK293 Cells , Oxidation-Reduction , Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry
3.
Arch Biochem Biophys ; 733: 109485, 2023 01 01.
Article in English | MEDLINE | ID: mdl-36481268

ABSTRACT

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is known to be one of the targets of methylglyoxal (MGO), a metabolite of glycolysis that increased in diabetes. However, the mechanism of GAPDH inactivation in the presence of MGO is unclear. The purpose of the work was to study the reaction of GAPDH with MGO and to identify the products of the reaction. It was shown that incubation of recombinant human GAPDH with MGO leads to irreversible inactivation of the enzyme, which is accompanied by a decrease in SH-group content by approximately 3.3 per tetramer GAPDH. MALDI-TOF MS analysis showed that the modification of GAPDH with MGO results in the oxidation of the catalytic cysteine residues (Cys152) to form cysteine-sulfinic acid. In addition, 2 arginine residues (R80 and R234) were identified that react with MGO to form hydroimidazolones. Incubation of SH-SY5Y neuroblastoma cells with MGO resulted in the inactivation of GAPDH and inhibition of glycolysis. The mechanism of GAPDH oxidation in the presence of MGO suggests the participation of superoxide anion, which is formed during the reaction of amino groups with methylglyoxal. The role of GAPDH in protection against the damaging effect of ROS in cells in the case of inefficiency of MGO removal by the GSH-dependent glyoxalase system is discussed.


Subject(s)
Neuroblastoma , Pyruvaldehyde , Humans , Cysteine/metabolism , Magnesium Oxide , Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry
4.
Russ Chem Bull ; 71(11): 2460-2466, 2022.
Article in English | MEDLINE | ID: mdl-36569657

ABSTRACT

A new method for preparation of 4-hydroxy-3-nitro-1,4-dihydrotriazolo[5,1-c][1,2,4]-triazines using 1-nitro-2-morpholinoethylene and 3-diazo-1,2,4-triazoles is proposed. Antiviral activity against the Coxsackie B3 virus and electrochemical transformations of the prepared compounds are studied.

5.
Biomed Khim ; 68(1): 18-31, 2022 Jan.
Article in Russian | MEDLINE | ID: mdl-35221293

ABSTRACT

We have isolated fractions of 26S and 20S proteasomes were from the rabbit liver and the brain. According to mass spectrometric (MS) analysis, the 26S proteasome fractions from these organs contained catalytic and regulatory subunits characteristic of the proteasome core and regulatory subunits. The 20S fractions of brain and liver proteasomes contained only catalytic proteasome subunits. In addition to proteasome subunits, the isolated fractions contained components of the ubiquitin-proteasome system, ubiquitinated proteins, enzymes that play an important role in metabolic processes, cytoskeletal components, signaling, regulatory, and protective proteins, as well as proteins regulating gene expression, cell division, and differentiation. The abundance of a number of proteasome-associated proteins was comparable or exceeded the abundance of intrinsic proteasome components. About a third of the proteins common to all studied fractions (26S and 20S of brain and liver proteasomes) belong to the group of multifunctional proteins. Selective biosensor validation confirmed the affinity binding of proteins (aldolase, phosphoglycerate kinase) identified during MS analysis to the brain 20S proteasome. Comparison of the subproteomes of the 26S and 20S brain proteasomes showed that removal of components of the regulatory (19S) subparticles caused almost two-fold increase in the total number of individual proteins associated with the core part of the proteasome (20S). In the liver, the number of proteins associated with the core part of the proteasome remained basically unchanged after the removal of the components of the regulatory (19S) subparticles. This indicates that in the brain and, possibly, in other organs, proteins of the regulatory (19S) subunit play an important role in the formation of the proteasome interactome.


Subject(s)
Proteasome Endopeptidase Complex , Ubiquitinated Proteins , Animals , Brain/metabolism , Liver/metabolism , Proteasome Endopeptidase Complex/metabolism , Rabbits , Ubiquitin/metabolism
6.
Biochim Biophys Acta Gen Subj ; 1866(1): 130032, 2022 01.
Article in English | MEDLINE | ID: mdl-34627945

ABSTRACT

BACKGROUND: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is one of the major targets of NO in cells, especially in neurodegenerative diseases. S-Nitrosylation of GAPDH is accompanied by its translocation into the nucleus with subsequent apoptosis. The product of GAPDH modification by NO is considered to be S-nitrosylated GAPDH (GAPDH-SNO). However, this has not been confirmed by direct methods. METHODS: Products of GAPDH modification in the presence of the NO donor diethylamine NONOate were analyzed by MALDI- and ESI- mass spectrometry methods. RESULTS: The adduct between GAPDH and dimedone was detected by MALDI-MS analysis after incubation of S-nitrosylated GAPDH with dimedone, which points to the formation of cysteine-sulfenic acid (GAPDH-SOH) in the protein. Analysis of the protein hydrolysate revealed the incorporation of dimedone into the catalytic residue Cys150. An additional peak that corresponded to GAPDH-SNO was detected by ESI-MS analysis in GAPDH after the incubation with the NO donor. The content of GAPDH-SNO and GAPDH-SOH in the modified GAPDH was evaluated by different approaches and constituted 2.3 and 0.7 mol per mol GAPDH, respectively. A small fraction of GAPDH was irreversibly inactivated after NO treatment, suggesting that a minor part of the products includes cysteine-sulfinic or cysteine-sulfonic acids. CONCLUSIONS: The main products of GAPDH modification by NO are GAPDH-SNO and GAPDH-SOH that is presumably formed due to the hydrolysis of GAPDH-SNO. GENERAL SIGNIFICANCE: The obtained results are important for understanding the molecular mechanism of redox regulation of cell functions and the role of GAPDH in the development of neurodegenerative disorders.


Subject(s)
Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Nitric Oxide/chemistry , Animals , Catalysis , Cyclohexanones/chemistry , Cysteine/analogs & derivatives , Cysteine/chemistry , Hydrolysis , Nitric Oxide/metabolism , Oxidation-Reduction , Rabbits , Sulfenic Acids/chemistry
7.
Biomed Khim ; 67(1): 51-65, 2021 Jan.
Article in Russian | MEDLINE | ID: mdl-33645522

ABSTRACT

Mitochondrial dysfunction and ubiquitin-proteasome system (UPS) failure contribute significantly to the development of Parkinson's disease (PD). The proteasome subunit Rpn13 located on the regulatory (19S) subparticle play an important role in the delivery of proteins, subjected to degradation, to the proteolytic (20S) part of proteasome. We have previously found several brain mitochondrial proteins specifically bound to Rpn13 (Buneeva et al. (2020) Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 14, 297-305). In this study we have investigated the effect of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the neuroprotector isatin on the mitochondrial subproteome of Rpn13-binding proteins of the mouse brain. Administration of MPTP (30 mg/kg) to animals caused movement disorders typical of PD, while pretreatment with isatin (100 mg/kg, 30 min before MPTP) reduced their severity. At the same time, the injection of MPTP, isatin, or their combination (isatin + MPTP) had a significant impact on the total number and the composition of Rpn13-binding proteins. The injection of MPTP decreased the total number of Rpn13-binding proteins in comparison with control, and the injection of isatin prior to MPTP or without MPTP caused an essential increase in the number of Rpn13-binding proteins, mainly of the functional group of proteins participating in the protein metabolism regulation, gene expression, and differentiation. Selected biosensor validation confirmed the interaction of Rpn13 subunit of proteasome with some proteins (glyceraldehyde-3-phosphate dehydrogenase, pyruvate kinase, histones H2A and H2B) revealed while proteomic profiling. The results obtained testify that under the conditions of experimental MPTP-induced parkinsonism the neuroprotective effect of isatin may be aimed at the interaction of mitochondria with the components of UPS.


Subject(s)
Isatin , Neurotoxins , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , Animals , Brain/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Isatin/metabolism , Isatin/pharmacology , Mice , Mitochondria/metabolism , Neurotoxins/metabolism , Neurotoxins/pharmacology , Proteomics
8.
Biochemistry (Mosc) ; 84(11): 1359-1374, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31760923

ABSTRACT

The review summarizes the data of our research and published studies on the ubiquitination of brain mitochondrial proteins and its changes during the development of experimental parkinsonism and administration of the neuroprotector isatin (indole-2,3-dione) with special attention to the mitochondrial ubiquitin-conjugating system and location of ubiquitinated proteins in these organelles. Incubation of brain mitochondrial fraction with biotinylated ubiquitin in vitro resulted in the incorporation of biotinylated ubiquitin in both mitochondrial and mitochondria-associated proteins. According to the interactome analysis, the identified non-ubiquitinated proteins are able to form tight complexes with ubiquitinated proteins or their partners and components of mitochondrial membranes, in which interactions of ubiquitin chains with the ubiquitin-binding protein domains play an important role. The studies of endogenous ubiquitination in the total brain mitochondrial fraction of C57Bl mice performed in different laboratories have shown that mitochondrial proteins represent about 30% of all ubiquitinated proteins. However, comparison of brain subproteomes of mitochondrial ubiquitinated proteins reported in the literature revealed significant differences both in their composition and involvement of identified ubiquitinated proteins in biological processes listed in the Gene Ontology database. The development of experimental parkinsonism in C57Bl mice induced by a single-dose administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) resulted in a decrease in the total number of mitochondrial ubiquitinated proteins and increase in the number of oxidized mitochondrial proteins containing the ubiquitin signature (K-ε-GG). Comparison of ubiquitinated proteins associated with the mouse brain mitochondrial fraction and mouse brain mitochondrial proteins bound to the proteasome ubiquitin receptor (Rpn10 subunit) did not reveal any common proteins. This suggests that ubiquitination of brain mitochondrial proteins is not directly related to their degradation in the proteasomes. Proteomic profiling of brain isatin-binding proteins identified enzymes involved in the ubiquitin-conjugating system functioning. Mapping of the identified isatin-binding proteins to known metabolic pathways indicates their participation in the parkin (E3 ubiquitin ligase)-associated pathway (CH000000947). The functional links involving brain mitochondrial ubiquitinated proteins were found only in the group of animals with the MPTP-induced parkinsonism, but not in animals treated with MPTP/isatin or isatin only. This suggests that the neuroprotective effect of isatin may be associated with the impaired functional relationships of proteins targeted to subsequent degradation.


Subject(s)
Brain/metabolism , Parkinsonian Disorders/pathology , Ubiquitin/metabolism , Animals , Autophagy , Metabolic Networks and Pathways , Mitochondria/metabolism , Mitochondrial Proteins/metabolism , Parkinsonian Disorders/metabolism , Parkinsonian Disorders/veterinary , Proteasome Endopeptidase Complex/metabolism , Ubiquitination
9.
Biomed Khim ; 65(4): 306-310, 2019 Jun.
Article in Russian | MEDLINE | ID: mdl-31436171

ABSTRACT

It becomes increasingly clear that ubiquitination of cellular proteins is not an indispensable prerequisite of their degradation in proteasomes. There are a number of proteins to be eliminated which are not pre-ubiquitinated for their recognition by regulatory subcomplex of 26S proteasome, but which directly interact with the 20S proteasome core particle (20S proteasome). The obligatory precondition for such interaction consists in existence of disordered (hydrophobic) fragments in the target protein. In this study we have investigated the interaction of a number of multifunctional (moonlighting) proteins (glyceraldehyde-3-phosphate dehydrogenase (GAPDH), aldolase, pyruvate kinase) and neurodegeneration-related proteins (a-synuclein, myelin basic protein) with 20S proteasome immobilized on the SPR-biosensor chip and stabilized by means of a bifunctional agent dimethyl pimelimidate (in order to prevent possible dissociation of this subcomplex). Only two of all investigated proteins (aldolase and pyruvate kinase) interacted with the immobilized 20S proteasome (Kd of 8.17´10-7 M and 5.56´10-7 M, respectively). In addition to earlier detected GAPDH ubiquitination, mass spectrometric analysis of the studied proteins revealed the presence of the ubiquitin signature (Lys-e-Gly-Gly) only in aldolase. Oxidation of aldolase and pyruvate kinase, which promotes elimination of proteins via their direct interaction with 20S proteasome, caused a 2-3-fold decrease in their Kd values as comparison with this parameter obtained for the intact proteins. The results of this study provide further evidence for direct interaction of both ubiquitinated proteins (aldolase), and non-ubiquitinated proteins (pyruvate kinase) with the 20S proteasome core particle (20S proteasome). The effectiveness of this interaction is basically equal for the ubiquitinated proteins and non-ubiquitinated proteins.


Subject(s)
Biosensing Techniques , Proteasome Endopeptidase Complex/chemistry , Ubiquitinated Proteins/chemistry , Humans , Ubiquitin , Ubiquitination
10.
Biomed Khim ; 64(5): 423-428, 2018 Sep.
Article in Russian | MEDLINE | ID: mdl-30378558

ABSTRACT

Amyloid-ß peptide (1-42) (Aß1-42) is a key player in the development and progression of Alzheimer's disease (AD) and related pathologies, determined by formation of protein aggregates in the central nervous system. Aß1-42 binding to crucial intracellular targets (and their subsequent inactivation) obviously represents one of the earliest events preceding extracellular pathogenic oligomerization/aggregation of Aß1-42. It is reasonable to expect that dissociation of the Aß1-42 complexes with intracellular proteins by means of inhibitors followed by subsequent degradation of Aß1-42 would not only protect critically important proteins but also prevent intracellular accumulation of Aß1-42. The aim of this study was to investigate the effect of the neuroprotector isatin (100 mM) on interaction of known Aß-binding proteins, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and pyruvate kinase, with Aß1-42 and its fragments (Aß1-28, Aß12-28, Aß25-35). Aß1-42 and its fragments (Aß1-28, Aß12-28, Aß25-35) immobilized on the Biacore optical biosensor chip interacted with GAPDH and pyruvate kinase. The lowest and basically equal Kd values were determined for GAPDH and pyruvate kinase complexes with immobilized Aß1-42 and Aß25-35. The presence of 100 mM isatin caused a significant (more than fivefold) increase in the Kd values for GAPDH complexes with all Aß peptides except Aß1-28. In contrast to GAPDH isatin increased dissociation of pyruvate kinase complexes only with Aß1-42 (causing a 30-fold increase in Kd) and to a lesser extent with Aß12-28 and Aß25-35 (a 10-fold increase in Kd). It should be noted that in the presence of isatin the Kd values for GAPDH and pyruvate kinase complexes with all Aß studied were in a narrower concentration range (10-7 M - 10-6 M) than in the absence of this neuroprotector (10-8 M - 10-6 M). Data obtained suggest existence of principal possibility of (pharmacological) protection of crucial intracellular targets against both Aß1-42, and its aggressive truncated peptides (Aß25-35).


Subject(s)
Isatin/metabolism , Alzheimer Disease , Amyloid beta-Peptides , Glyceraldehyde-3-Phosphate Dehydrogenases , Humans , Peptide Fragments
11.
Biochemistry (Mosc) ; 82(9): 1042-1047, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28988533

ABSTRACT

Recent proteomic profiling of mouse brain preparations using the ubiquitin receptor, Rpn10 proteasome subunit, as an affinity ligand revealed a representative group of proteins bound to this sorbent (Medvedev, A. E., et al. (2017) Biochemistry (Moscow), 82, 330-339). In the present study, we investigated interaction of the Rpn10 subunit of proteasomes with some of these identified proteins: glyceraldehyde-3-phosphate dehydrogenase (GAPDH), pyruvate kinase, and histones H2A and H2B. The study revealed: (i) quantitative affinity interaction of the proteasome subunit immobilized on a Biacore-3000 optical biosensor cuvette with both the GAPDH (Kd = 2.4·10-6 M) and pyruvate kinase (Kd = 2.8·10-5 M); (ii) quantitative high-affinity interaction of immobilized histones H2A and H2B with the Rpn10 subunit (Kd values of 6.5·10-8 and 3.2·10-9 M, respectively). Mass spectrometric analysis revealed the presence of the ubiquitin signature (GG) only in a highly purified preparation of GAPDH. We suggest that binding (especially high-affinity binding) of non-ubiquitinated proteins to the Rpn10 proteasome subunit can both regulate the functioning of this proteasomal ubiquitin receptor (by competing with ubiquitinated substrates) and promote activation of other pathways for proteolytic degradation of proteins destined to the proteasome.


Subject(s)
Proteasome Endopeptidase Complex/metabolism , Ubiquitinated Proteins/metabolism , Animals , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Histones/metabolism , Humans , Kinetics , Protein Binding , Pyruvate Kinase/metabolism , RNA-Binding Proteins , Rabbits
12.
Biochemistry (Mosc) ; 82(3): 330-339, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28320274

ABSTRACT

Mitochondria play an important role in molecular mechanisms of neuroplasticity, adaptive changes of the brain that occur in the structure and function of its cells in response to altered physiological conditions or development of pathological disorders. Mitochondria are a crucial target for actions of neurotoxins, causing symptoms of Parkinson's disease in various experimental animal models, and also neuroprotectors. Good evidence exists in the literature that mitochondrial dysfunction induced by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) influences functioning of the ubiquitin-proteasomal system (UPS) responsible for selective proteolytic degradation of proteins from various intracellular compartments (including mitochondria), and neuroprotective effects of certain antiparkinsonian agents (monoamine oxidase inhibitors) may be associated with their effects on UPS. The 19S proteasomal Rpn10 subunit is considered as a ubiquitin receptor responsible for delivery of ubiquitinated proteins to the proteasome proteolytic machinery. In this study, we investigated proteomic profiles of mouse brain mitochondrial Rpn10-binding proteins, brain monoamine oxidase B (MAO B) activity, and their changes induced by a single-dose administration of the neurotoxin MPTP and the neuroprotector isatin. Administration of isatin to mice prevented MPTP-induced inactivation of MAO B and influenced the profile of brain mitochondrial Rpn10-binding proteins, in which two pools of proteins were clearly recognized. The constitutive pool was insensitive to neurotoxic/neuroprotective treatments, while the variable pool was specifically influenced by MPTP and the neuroprotector isatin. Taking into consideration that the neuroprotective dose of isatin used in this study can result in brain isatin concentrations that are proapoptotic for cells in vitro, the altered repertoire of mitochondrial Rpn10-binding proteins may thus represent a part of a switch mechanism from targeted elimination of individual (damaged) proteins to more efficient ("global") elimination of damaged organelles and whole damaged cells.


Subject(s)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacokinetics , Brain/metabolism , Carrier Proteins/metabolism , Isatin , MPTP Poisoning/metabolism , Mitochondria/metabolism , Nerve Tissue Proteins/metabolism , Neuroprotective Agents , Neurotoxins , Animals , Brain/pathology , Isatin/pharmacokinetics , Isatin/pharmacology , MPTP Poisoning/pathology , Male , Mice , Monoamine Oxidase/metabolism , Neuroprotective Agents/pharmacokinetics , Neuroprotective Agents/pharmacology , Neurotoxins/pharmacokinetics , Neurotoxins/toxicity , RNA-Binding Proteins
13.
Biomed Khim ; 62(6): 720-724, 2016 Nov.
Article in Russian | MEDLINE | ID: mdl-28026818

ABSTRACT

The amyloid-beta peptide 1-42 formed during proteolytic processing of the amyloid precursor protein (APP) plays a key role in the development or progression of Alzheimer's disease (AD) and other pathologies associated with formation of protein aggregates in the central nervous system. Recent proteomic profiling of mouse and rat brain preparations by means of beta-amyloid peptide immobilized on Affigel-10 revealed a large group of amyloid-binding proteins (n>80). Many (about 25%) of these proteins were previously identified as isatin-binding proteins. The aim of this study was to validate direct interaction between beta-amyloid peptide and highly purified intact and oxidized peroxiredoxin, M-type pyruvate kinase, alpha-enolase, and the effect of isatin on this interaction. The study performed using SPR-based Biacore 3000 and Biacore X100 biosensors has shown that all the proteins form molecular complexes with immobilized beta-amyloid peptide. The Kd values for these complexes varied from 8.36х10-8 M (peroxiredoxin) to 1.97х10-6 M (alpha-enolase). Oxidative modification of investigated proteins caused opposite effects on complexes of these peptides with beta-amyloid. The endogenous neuroprotector isatin increased dissociation of complexes formed by beta-amyloid peptide with both intact proteins (peroxiredoxin, glyceraldehyde-3-phosphate dehydrogenase) and/or oxidized proteins (peroxiredoxin, pyruvate kinase) used in this study.


Subject(s)
Amyloid beta-Protein Precursor/chemistry , Isatin/chemistry , Neuroprotective Agents/chemistry , Surface Plasmon Resonance , Amyloid beta-Protein Precursor/metabolism , Animals , Humans , Isatin/metabolism , Mice , Neuroprotective Agents/metabolism , Protein Binding , Rats
14.
Biomed Khim ; 62(2): 160-3, 2016.
Article in Russian | MEDLINE | ID: mdl-27143373

ABSTRACT

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a classical glycolytic redox sensitive enzyme, exhibits various non-glycolytic functions, which are considered to be especially important for progression of various neurodegenerative diseases. GAPDH binds isatin (indole-dione-2,3), an endogenous indole often used as a parent component in numerous derivatives demonstrating diverse pharmacological (including neuroprotector) activities. In this study we have investigated binding of intact and mildly oxidized GAPDH to immobilized isatin, using an optical biosensor technique, employing surface plasmon resonance (SPR), and the effect of isatin as a probe for this binding. Mild GAPDH oxidation by 70 mM H(2)O(2) increased enzyme dissociation from immobilized isatin. Since GAPDH is considered as a putative target for various neuroprotector agents, this suggests that its redox state determines sensitivity to neuroprotective agents, and oxidative stress typical for various neurodegenerative disorders may significantly reduce pharmacological effectiveness of such compounds.


Subject(s)
Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Isatin/metabolism , Biosensing Techniques , Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry , Isatin/chemistry , Neuroprotective Agents/pharmacology , Oxidation-Reduction , Oxidative Stress , Surface Plasmon Resonance
15.
Vestn Ross Akad Med Nauk ; (3-4): 36-42, 2014.
Article in Russian | MEDLINE | ID: mdl-25306594

ABSTRACT

The article presents a review of the data, which reflects the relevance and modern views on the problem of retinopathy of prematurity, including statistical and epidemiologic data on nosology. Various pathogenetic theories of onset and progression of this disease are discussed. A clear correlation depending on the degree of prematurity, body weight and physical condition of the newborn and the risk of disease is mentioned. The summation of etiology aspects, as well as pathogenesis, classification of clinical forms and the modern approach to the diagnostics is of a quite interest. The article also describes different treatment strategies which include various methods of conservative therapy and surgery, depending on the course and stage of disease. Rehabilitation activities for children who had come through some stage of retinopathy of prematurity and are at risk for the formation of different ophthalmopathology such as refractive errors and pathology of binocular vision in the future and require a subsequent long-term monitoring in the office catamnesis are itemized. The importance of interaction between ophthalmologists and neonatologists at all stages of neonatal screening for providing timely specialized care in order to minimize the occurrence of retinopathy and prevent progression to disabling stages, as well as to improve the quality of life of these patients is shown.


Subject(s)
Neonatal Screening , Retinopathy of Prematurity , Disease Management , Gestational Age , Humans , Infant Care/methods , Infant Care/organization & administration , Infant, Newborn , Infant, Premature , Neonatal Screening/methods , Neonatal Screening/organization & administration , Retinopathy of Prematurity/diagnosis , Retinopathy of Prematurity/epidemiology , Retinopathy of Prematurity/etiology , Retinopathy of Prematurity/physiopathology , Retinopathy of Prematurity/therapy , Risk Factors , Secondary Prevention
16.
Biomed Khim ; 60(6): 615-22, 2014.
Article in Russian | MEDLINE | ID: mdl-25552499

ABSTRACT

Protein ubiquitination is considered as an important mechanism that is responsible not only for specific labeling of proteins for their subsequent degradation but also for localization of proteins in the cell and regulation of protein-protein interactions. In the context of protein-protein interactions binding of (mono/poly)ubiquitinated molecules to proteins containing specific ubiquitin binding domains appear to play the decisive role. Although formation of the ubiquitin interactome has been demonstrated for cytosol, involvement of mitochondria and associated extramitochondrial proteins into such interactions still requires detailed investigation. In this study using an optical biosensor we have demonstrated binding of proteins of mouse brain mitochondrial lysates to immobilized monomeric ubiquitin. Model purified proteins, which are known to be associated with the outer mitochondrial compartment (glyceraldehyde-3-phosphate dehydorgenase, creatine phosphokinase), interacted with immobilized ubiquitin as well as with each other. This suggests that (poly)ubiquitinated chains may be involved in protein-protein interactions between ubiquitinated and non-ubiquitinated proteins and thus may contribute to formation of (mitochondrial) ubiquitin subinteractome.


Subject(s)
Creatine Kinase/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating)/metabolism , Immobilized Proteins/metabolism , Mitochondria/metabolism , Mitochondrial Proteins/metabolism , Protein Processing, Post-Translational , Ubiquitin/metabolism , Animals , Biosensing Techniques , Brain Chemistry , Cattle , Creatine Kinase/chemistry , Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating)/chemistry , Immobilized Proteins/chemistry , Mice , Mitochondria/chemistry , Mitochondrial Proteins/chemistry , Muscle, Skeletal/chemistry , Protein Binding , Rabbits , Ubiquitin/chemistry , Ubiquitination
17.
Gig Sanit ; (1): 45-8, 2010.
Article in Russian | MEDLINE | ID: mdl-20376936

ABSTRACT

A comprehensive study of the state of urban soils revealed the altered structural and functional organization of microbiocenosis versus that of the soils of intact forest ecosystems. The indicator microbial and biochemical parameters of the state of the soils under urban technological pressure were identified. The findings may be used to evaluate the natural environment, to make an urban environmental monitoring.


Subject(s)
Cities , Environmental Health/organization & administration , Environmental Monitoring/methods , Soil Microbiology/standards , Soil Pollutants/analysis , Humans , Russia
18.
Kardiologiia ; 48(1): 24-9, 2008.
Article in Russian | MEDLINE | ID: mdl-18260992

ABSTRACT

PURPOSE: We tested the hypothesis that serum heart fatty-acid binding protein (FABP), an early marker of myocardial necrosis, is related to prognosis of patients hospitalized because of worsening heart failure (HF). METHODS: Sixty nine patients (64% men, age 66.6 +/- 11.0 years) with NYHA class II, III, IV HF (1, 18, and 50 patients, respectively) at hospital admission were followed for 6-12 (mean 11.6 +/- 1.3) months. Forty seven patients (68.1%) had history of myocardial infarction (MI), 56 (81.2%) - hypertension, 15 (21.7%) -- diabetes, and 17 (24.6%) had echocardiographical signs of aortic stenosis. Median left ventricular ejection fraction was 28%. Serum FABP, cardiac troponin I (Tn I) and N-aminoterminal pro brain natriuretic peptide (NT proBNP) were measured within 3 days after admission ( " admission " levels) and 2 weeks later (minimal hospital stay). Manufacturer recommended upper limits of norm (ULN) were 4.0 ng/ml for FABP, 0.35 ng/ml for Tn I, 0.1 ng/ml for NT proBNP. RESULTS: Median admission FABP was insignificantly higher than level measured 2 weeks later (4.17 vs 4.03 ng/ml, p=0.069). FABP exceeded ULN in 38 (55.1%) patients and in 35 (50.7%) patients at admission and in 2 weeks, respectively (p=0.65). Median admission NT proBNP was significantly higher than 2 weeks level (13.23 vs 6.02 ng/ml, p < 0.0001). Median admission and 2-weeks levels of Tn I were similar and greatly lower than ULN. There were 27 all cause deaths (39.1%) during follow up. Median admission levels of TnI, FABP and NT proBNP were similar in patients who died and survived. Two weeks NT proBNP was significantly higher in patients who died (8.65 vs 3.62 ng/ml, p=0.012). ROC curve derived cut-off levels of FABP and NT proBNP (3.31 ng/ml and 3.5 ng/ml, respectively) were used in univaritate regression analysis. According to this analysis FABP >or= 3.31 ng/ml was related to occurrence of death (OR 3.54; 95% CI 1.03-12.17, p=0.044). FABP and variables with p > 0.1 (age, history of MI and diabetes, regular treatment with nitrates, signs of aortic stenosis, pulmonary rales at admission, and 2 weeks level of NT proBNP >or = cut-off) were included into multivariate logistic regression model. Independent predictors of death were aortic stenosis (OR 31.67; 95% CI 6.11-164.00) and NT proBNP >or= 3.5 ng/ml (OR 5.75; 95%CI 1.69- 19.52). CONCLUSION: In this group of patients hospitalized due to worsening of HF admission values of neither FABP nor other biomarkers studied were predictors of death during about 1 year of follow up. FABP level after 2 weeks of hospital stay was related to occurrence of death but as predictor was inferior to NT-proBNP measured at the same time point.


Subject(s)
Fatty Acid-Binding Proteins/blood , Heart Failure/blood , Heart Failure/mortality , Inpatients , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Cause of Death , Disease Progression , Female , Follow-Up Studies , Humans , Male , Middle Aged , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Prognosis , Retrospective Studies , Russia/epidemiology , Severity of Illness Index , Survival Rate , Troponin I/blood
19.
Biomed Khim ; 54(6): 720-6, 2008.
Article in Russian | MEDLINE | ID: mdl-19205432

ABSTRACT

Insertion of exogenous ubiquitin into rat brain mitochondria in the presence of ATP and the ATP-regenerating system (creatine phosphate/creatine phosphokinase) is accompanied by the increase in: i) sensitivity of mitochondrial monoamine oxidases A and B to proteolytic inactivation (by trypsin and papain, respectively); ii) inhibition by mechanism based inhibitor, pargyline; iii) in [3H]-pargyline insertion into mitochondria (+48 +/- 11%, p<0.01). There was almost fivefold increase in [3H]-pargyline incorporation into the fraction obtained by immunoprecipitation of mitochondrial proteins with anti-ubiquitin antiserum and protein A Sepharose. This suggests that MAO is a potential substrate for ubiquitination in vitro. However, the content of the tritium label in this fraction was less than 0.1% and not more than 0.25% of total radioactivity of [3H]pargyline bound to control and ATP-ubiquitin treated mitochondria, respectively. Insertion of ubiquitin into mitochondria did not influence molecular masses of [3H]-pargyline labeled proteins (MAO A and B). These results suggest that direct ubiquitination of MAO insignificantly contributes to marked changes in sensitivity of MAO A and MAO B to proteolysis and specific inhibition found under these experimental conditions. It is possible that more complex processes are involved into realization of these effects during ATP-dependent ubiquitin incorporation into mitochondria.


Subject(s)
Mitochondria/metabolism , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Pargyline/pharmacology , Ubiquitin/metabolism , Animals , Brain/ultrastructure , Electrophoresis, Polyacrylamide Gel , Hydrolysis , In Vitro Techniques , Rats
20.
Biomed Khim ; 53(5): 603-8, 2007.
Article in Russian | MEDLINE | ID: mdl-18078075

ABSTRACT

Incubation of rat brain mitochondria with ubiquitin and ATP followed by subsequent mitochondria sedimentation was accompanied by reduction of ubiquitin content in the supernatant. This decrease was more pronounced in the presence of ATP-regenerating system in the incubation medium (creatine phosphate/creatine phosphokinase). This ubiquitin incorporation into brain mitochondria observed only in the presence of ATP in the incubation medium increased sensitivity of monoamine oxidases (MAO) A and B to proteolytic inactivation by trypsin and papain, respectively. (Ubiquitin did not influence sensitivity of MAO B to trypsin and MAO A to papain). The data obtained suggest that ubiquitin incorporation into rat brain mitochondria increases susceptibility of MAOs to certain exogenous proteases, however, it remains unclear whether these changes stem from direct MAO-ubiquitin conjugation or reflect alterations in the membrane environment of these enzymes.


Subject(s)
Brain/enzymology , Mitochondria/enzymology , Monoamine Oxidase/chemistry , Peptide Hydrolases/chemistry , Ubiquitin/chemistry , Adenosine Triphosphate/chemistry , Animals , Creatine Kinase/chemistry , Monoamine Oxidase/metabolism , Papain/chemistry , Peptide Hydrolases/metabolism , Phosphocreatine/chemistry , Rats , Trypsin/chemistry , Ubiquitin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...